Advertisement

Search Results for "Aspirin Mg Per Tablet"

08:48 EDT 20th May 2013 | BioPortfolio

Original Source: Bayer [Bayer Corporation Consumer Care Division]

Bayer Advanced Aspirin Extra Strength 500 mg Coated Tablet

Matching Channels

Aspirin

Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug

Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...

Pancreatic Cancer

The pancreas secretes a number of important hormones into the digestive tract and the blood stream. Cancers are most commonly exocrine than endocrine (neuroendocrine) tumors. Functional tumors secre...

Cardiovascular

Cardiovascular diseases (CVD) are the world’s most serious disease, killing 17.1 million people a year. CVDs are a group of disorders affecting the heart and blood vessels.  The most...

Selective monoamine oxidase type B MAOB inhibitors

The clinical benefit of monoamine oxidase type B (MAO-B) inhibitors is thought to arise from an ability of these medications to enhance the level of dopamine by decreasing the catabolism. Additional...

Matching News

Aspirin Use and Risk of Macular Degeneration—Reply

In Reply: Dr Nowroozzadeh noted that the examination question used to identify regular aspirin users was inappropriate because persons regularly using aspirin may consume it more than twice per week o...

AHA: PPI-Aspirin Pill Eases GI Ulcers in Heart Patients (CME/CE)

LOS ANGELES (MedPage Today) -- The incidence of gastric ulcers was reduced by more than half among individuals taking a combination tablet that added a proton pump inhibitor to aspirin for secondary p...

Aspirin Plus Dipyridamole vs Aspirin Only in Ischemic Stroke

Reports suggest that patients who suffer ischemic stroke while treated with aspirin have less severe strokes than those who aren't on aspirin. How does the addition of dipyridamole effect outcomes?...

An Aspirin a Day Can Take the Eyesight Away

Sturgeon Bay, WI (PRWEB) April 29, 2013 Sturgeon Bay, Wisconsin Chiropractor and Naturopath, Dr. J G Moellendorf, DC, ND, LCP notes that aspirin is one of the most commonly used drugs, with ove...

What Is the Key to Aspirin's Benefit in CRC?

Why does aspirin increase survival only in some colon cancer patients? Dr. David Kerr reports on a study suggesting a PIK3CA mutation may be a predictive marker for use of aspirin as adjuvant therapy....

Aspirin and Cancer Risk and Mortality

Aspirin and cancer risk is in the news again—and the link is still unclear. Two studies published early online in the Journal of Clinical Oncology evaluated the relationship between aspirin and canc...

Aspirin Therapy

Aspirin, also known as acetylsalicylic acid, has been used for many years to relieve pain, reduce fevers, and improve inflammation. Aspirin is one of the nonsteroidal anti-inflammatory drugs (NSAIDs)...

Bulk of evidence supports aspirin safety in patients with AMD

Though the association of aspirin use and age-related macular degeneration is controversial, the totality of evidence suggests there is no major harmful effect of aspirin use.

Matching PubMed Articles

Can resistance to aspirin be reversed after an additional dose?

Aspirin resistance or aspirin non-responsiveness is a recently described phenomenon which has been consistently associated with an increased risk of cardiovascular events. This study was designed to d...

Aspirin resistance in patients with acute ischemic stroke.

Aspirin is used in ischemic stroke therapy. However, some patients are not responsive to the antithrombotic action of aspirin. The aim of this study was to assess the prevalence of aspirin resistance...

Aspirin for preventing venous thromboembolism.

To the Editor: In their report on the Aspirin to Prevent Recurrent Venous Thromboembolism (ASPIRE) trial, Brighton et al. (Nov. 22 issue)(1) describe a nonsignificant decrease in the rate of recurrent...

Aspirin for preventing venous thromboembolism.

To the Editor: In their report on the Aspirin to Prevent Recurrent Venous Thromboembolism (ASPIRE) trial, Brighton et al. (Nov. 22 issue)(1) describe a nonsignificant decrease in the rate of recurrent...

Aspirin for preventing venous thromboembolism.

To the Editor: In their report on the Aspirin to Prevent Recurrent Venous Thromboembolism (ASPIRE) trial, Brighton et al. (Nov. 22 issue)(1) describe a nonsignificant decrease in the rate of recurrent...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement